Status:
COMPLETED
Efficacy Study of Bromfenac Ophthalmic Solution in Patients Undergoing Cataract Surgery
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Pain
Inflammation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Efficacy study of Bromfenac Ophthalmic Solution in cataract surgery
Eligibility Criteria
Inclusion
- Male or female at least 18 years of age who are scheduled for unilateral cataract surgery
Exclusion
- Have known hypersensitivity to bromfenac or to any component of the investigational product
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
299 Patients enrolled
Trial Details
Trial ID
NCT00853970
Start Date
February 1 2009
End Date
December 1 2009
Last Update
January 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISTA Pharmaceuticals, Inc.
Irvine, California, United States, 92618